Objective: To gain a description of the prevalence and time course of vasospasm in children suffering moderate-to-severe traumatic brain injury. Design: A prospective, observational study was performed. Children with a diagnosis of traumatic brain injury, a Glasgow Coma Score less than or equal to 12, and abnormal head imaging were enrolled. Transcranial Doppler ultrasound was performed to identify and follow vasospasm. Diagnostic criteria included flow velocity elevation more than or equal to 2 sd above age and gender normal values for the middle cerebral and basilar arteries. Additional criteria required for vasospasm diagnosis in the middle cerebral artery was a ratio of flow in the middle cerebral artery to extracranial internal carotid artery more than or equal to 3. Interventions: None. Measurements and Main Results: Sixty-nine children were included. The prevalence of middle cerebral artery vasospasm in children with moderate traumatic brain injury (Glasgow Coma Score, 9-12) was 8.5% and was 33.5% in those with severe traumatic brain injury (Glasgow Coma Score, ≤ 8). The prevalence of basilar artery vasospasm in children with moderate traumatic brain injury was 3% and with severe traumatic brain injury was 21%. Mean time to onset of vasospasm was 4 days (± 2 d) in the middle cerebral arteries and 5 days (± 2.5 d) in the basilar artery. Mean duration of vasospasm in the middle cerebral artery was 2 days (± 2 d) and 1.5 days (± 1 d) in the basilar artery. Children in whom vasospasm developed were more likely to have been involved in motor vehicle accidents, had higher Injury Severity Scores, had fever at admission, and had lower Glasgow Coma Score scores. Good neurologic outcome (Glasgow Outcome Score Extended Pediatric version of ≥ 4) at 1 month from injury was seen in 76% of those with moderate traumatic brain injury without vasospasm and in 40% of those with vasospasm. In those with severe traumatic brain injury, good neurologic outcome was seen in 29% of those children without vasospasm and in 15% of those with vasospasm. Conclusions: Vasospasm occurs in a sizeable number of children with moderate and severe traumatic brain injury. Children in whom vasospasm developed were more likely to have been involved in a motor vehicle accident, had higher Injury Severity Scores, had fever at admission, and had lower Glasgow Coma scores than in those whom vasospasm did not develop. Based on these findings, we recommend aggressive screening for posttraumatic vasospasm in these patients. Future studies should establish the relationship between vasospasm and long-term functional outcomes and should also evaluate potential preventative or therapeutic options for vasospasm in these children. (Crit Care Med 2015; 43:674-685) Key Words: cerebral blood flow; pediatrics; secondary brain injury; transcranial Doppler ultrasound; traumatic brain injury; vasospasm T raumatic brain injury (TBI) is a major cause of death and disability in children worldwide. Each year in the United States, over 475,000 children visit the emergency department due to head trauma. Of these, 35 ,000 are hospitalized and 2,600 die as a direct result of their injury (1) . The survivors of TBI and their families commonly cope with long-term behavioral issues, cognitive deficits, and motor disabilities. Additionally, the economic consequences of TBI are enormous. Estimates for the average lifetime cost of care for a person with severe TBI range from $600,000 to $1,875,000 (2) .
Injury due to head trauma is suffered in two distinct phases. The primary injury occurs at the moment of impact and results from mechanical forces that cause direct disruption of the brain parenchyma. The primary injury may be preventable, but it is irreversible. In the initial minutes to weeks following the primary injury, endogenous factors such as metabolic, cellular, and biochemical derangements and other complications such as hypoxia, hypotension, and intracranial hypertension lead to additional neuronal cell injury and death. This phase is known as "secondary brain injury." Secondary brain injury may be both preventable and treatable. Vasospasm, through reduction of cerebral blood flow with subsequent ischemia, may be an unrecognized phenomenon that contributes to secondary brain injury in pediatric head trauma patients.
There is a paucity of research that has evaluated vasospasm in this population. We hypothesize that vasospasm occurs in a significant percentage of children who have suffered TBI. We designed this prospective, observational study to evaluate the prevalence, time to onset, and duration of vasospasm in children with moderate-to-severe TBI. In addition, we explored risk factors for the development of vasospasm in these patients.
METHODS

Study Population
We performed a prospective, observational study in a tertiary care, level 1 pediatric trauma center. The study was approved by the institutional review board. Informed consent was obtained by parents before enrollment. Children 1 day to 17 years old admitted with a diagnosis of moderate-to-severe head trauma (postresuscitation Glasgow Coma Score [GCS] ≤ 12) and abnormal head imaging were recruited. Children were excluded if they were deemed to have suffered a nonsurvivable injury and had a GCS of 3 with fixed and dilated pupils. Children were also excluded if they had a previous diagnosis of severe developmental disability or mental retardation. Demographic data including age, gender, mechanism of injury, Injury Severity Score (ISS), and postresuscitation GCS were obtained. Those children with a postresuscitation GCS of 9-12 were considered to have suffered moderate TBI and those with a postresuscitation GCS less than or equal to 8 were considered to have suffered severe TBI. Admission temperature (rectal), serum chemistry, and complete blood cell counts were prospectively collected.
General Management Protocol
All patients received routine ICU care. Patients with moderate TBI underwent frequent neurologic checks. Patients with severe TBI were treated following the Society of Critical Care Medicine Guidelines (3). Children with mass lesions underwent primary decompressive craniotomy with resection of the mass lesion at the discretion of the neurosurgical attending physician. Other care included tracheal intubation, elevation of the head of the bed to 30 degrees, and placement of an intracranial pressure (ICP) monitor. Ventriculostomy was placed when technically feasible. Subsequent cerebrospinal fluid drainage was taken if ventriculostomy was present. If ventriculostomy could not be inserted, an intraparenchymal monitor was placed (Camino or Licox; Integra Neurosciences, Plainsboro, NJ). The type of intraparenchymal monitor that was used was left to the discretion of the neurosurgical attending physician. All patients with severe TBI received sedation with infusions of fentanyl and versed that were titrated according to the Face, Legs, Activity, Cry, Consolability (FLACC) score. The FLACC score is a standardized, validated measure of pain, agitation, and sedation for children in the PICU (4, 5). Target score was less than 3. Sedation infusions were increased by 10% every 10 minutes if FLACC scores were above the goal.
Elevation in ICP (≥ 20 mm Hg) despite adequate sedation was treated with osmolar therapy followed by neuromuscular blockade. A bolus dose of hypertonic saline (5 mL/kg of 3% sodium chloride) was given initially. This was followed by a continuous infusion (starting at 1 mL/kg/hr) to maintain sodium levels in the range of 150-165 mEq/L. If ICP was more than or equal to 20 mm Hg and serum sodium was less than 150 mEq/L, repeat boluses of 5 mL/kg of 3% sodium chloride were given until serum sodium level reached the goal range. For each bolus dose of hypertonic saline required, the infusion was increased by 0.5-1 mL/kg/hr to maintain sodium in the target range. All patients requiring subsequent neuromuscular blockade underwent continuous electroencephalogram monitoring to ensure status epilepticus did not go unrecognized.
Careful control of ventilation (Paco 2 , 35-45 mm Hg) was undertaken in all patients. Second-tier therapies such as moderate hyperventilation (goal Paco 2 , 30-35 mm Hg), barbiturate coma, and decompressive craniectomy were used for refractory elevations in ICP. Age-appropriate cerebral perfusion pressure (CPP) (neonates ≥ 40 mm Hg, children 50-60 mm Hg, adolescents > 60 mm Hg) was maintained using fluid boluses to a central venous pressure more than 10 cm H 2 O followed by an epinephrine infusion.
CT
The initial postinjury CT was reviewed by a pediatric neuroradiologist. The presence or absence of intracranial hemorrhage patterns was noted (epidural hematoma, subdural hematoma, intraparenchymal hematoma, intraventricular hemorrhage, and subarachnoid hemorrhage). Basal cisterns were classified as open, compressed, or absent. Midline shift was classified as less than or greater than 5 mm. Diffuse edema was noted as absent or present. Skull fractures were classified as present or absent.
Transcranial Doppler Ultrasonography
Transcranial Doppler (TCD) ultrasonography was performed at the participant's bedside by one of two sonographers using a 2-MHz pulsed probe and commercially available TCD ultrasonography unit (Sonara Digital TCD; CareFusion, Middleton, WI). Middle cerebral arteries (MCAs), extracranial internal carotid arteries (EC-ICAs), and basilar arteries (BAs) were insonated at 1-mm intervals using the method described by Aaslid et al (6, 7) and Lindegaard et al (8) . Participants underwent an initial TCD within 24 hours of the injury. Daily ultrasounds were continued on all study participants through hospital day 8, discharge, or death, whichever occurred earliest. TCD examinations were only performed when no changes to the ventilator had occurred or treatments to augment CPP had been given within the previous hour. Physicians caring for study participants were blinded to the findings of the TCD examinations, and no specific interventions to treat vasospasm were carried out based on the results.
Diagnostic Criteria
Vasospasm was diagnosed in the anterior circulation when the mean middle cerebral artery flow velocity (V mca ) was more than or equal to 2 sds above the age and gender normal value, and the ratio of flow velocity in the MCA to flow velocity in the EC-ICA was more than or equal to 3 (9) (10) (11) . The ratio of flow in the MCA to EC-ICA is known as the "Lindegaard ratio." Values less than 3 are most consistent with hyperemia as a cause of elevated flow velocities, whereas values more than 3 are most consistent with vasospasm (8) . Posterior circulation vasospasm was diagnosed when the mean basilar artery flow velocity (V ba ) was more than 2 sds above the age and gender normal value (9) (10) (11) . These criteria, which are based on expert consensus, have been used in previous studies to diagnose abnormal flow velocities in children (9) (10) (11) (12) . In addition, a control group of 15 intubated, sedated, surgical, or non-TBI trauma patients of various ages and genders underwent serial TCD ultrasounds to ensure that this adopted definition for vasospasm did not exist in those without TBI.
Clinical Outcome
Short-term outcome was assessed in all patients using the Glasgow Outcome Scale Extended Pediatric version (GOS-E Peds) at 1 month from the time of injury. The GOS-E Peds provides an age-appropriate, valid measurement of neurologic outcome for infants and children less than 18 years with TBI (13 For this study, good neurologic outcome was considered to be a GOS-E Peds less than or equal to 4 (lower moderate disability or better) and a poor neurologic outcome was considered to be a GOS-E Peds of 5-8 (upper severe disability or worse).
Statistical Methods
Descriptive continuous data were reported as mean ± sd, and categorical data were reported as a percentage. Univariate analysis was performed using Fisher exact test for categorical variables and Mann-Whitney U test for continuous variables. Stepwise logistic regression analysis was used to confirm the independent contribution of age, gender, mechanism of injury, ISS, GCS score, and head imaging findings to the development of vasospasm. It was also used to identify independent contributors to the short-term GOS-E Peds. Statistical significance was assumed with a p value of less than 0.05. Statistical analysis was performed using SAS 9.3 (SAS Institute, Cary, NC).
RESUlTS
Eighty-three patients were screened. Six patients had suffered nonsurvivable injuries and were excluded. An additional two patients were excluded due to previously diagnosed developmental disability. In four patients, no parent was available to give consent and another two guardians refused to consent for the study. Sixty-nine patients were enrolled and included in the statistical analysis.
Demographic, clinical, and radiographic characteristics of participants are presented in Table 1 . Thirty patients suffered polytrauma and 39 suffered isolated head injury. Thirty-five patients suffered moderate TBI and 34 suffered severe TBI. In those children with severe TBI, 30 had an intracranial monitor placed (external ventricular drain, n = 16; Licox, n = 9; Camino, n = 5). Four patients had suffered abusive head trauma, and the neurosurgical attending did not feel as if data from an ICP monitor would be helpful in the management of these patients so one was not placed.
Osmolar therapy was used in 30 patients to control ICP. Mean sodium in this group was 156 (range, 150-163). Eighteen patients underwent subsequent neuromuscular blockade for ongoing ICP elevations following osmolar therapy. The mean ICP for patients requiring these therapies was 16 ± 3.2 over the study period. CPP was augmented to goal with epinephrine infusion (range, 0.05-0.8 μg/kg/min) in 16 patients.
Four children experienced refractory elevations in ICP despite the above-mentioned management strategies. All four of these patients were poor grade from the time of injury with an initial postresuscitation GCS of 3. All four were placed in a barbiturate coma and underwent hyperventilation to a Paco 2 of 30-35 mm Hg for ongoing ICP elevations. In one child, these measures controlled ICP elevations (ICP < 20 mm Hg). The other three patients underwent decompressive craniotomy for the management of refractory ICP elevations. All three of these children eventually met criteria for brain death despite aggressive management. On TCD evaluation, all three of these children had extremely low measured flow velocities that persisted despite aggressive management and thus did not meet study criteria for vasospasm. No patient was managed with significant hyperventilation (Paco 2 < 30 mm Hg) or with prophylactic or therapeutic hypothermia.
Nineteen patients met diagnostic criteria for vasospasm. These patients' mechanism of injury, clinical characteristics, and necessary therapies are noted in Table 2 . The prevalence of MCA vasospasm in children with moderate TBI was 8.5% compared with 33.5% in those with severe TBI. Thus, the entire cohort had an overall prevalence of MCA vasospasm of 21% (Fig. 1) . The prevalence of BA vasospasm in children with moderate TBI was 3% and with severe TBI was 21%, giving an overall prevalence of vasospasm of 12% in this vessel (Fig. 1) . Mean time to onset of vasospasm was 4 days (± 2 d) from injury in both the right and left MCA and 5 days (± 2.5 d) in the basilar artery (Fig. 2) . Mean duration of vasospasm was 2.5 days (± 2 d) in the anterior circulation and 1.5 days (± 1 d) in the posterior circulation (Fig. 3) . It should be noted, however, that some patients had onset of vasospasm as early as day 1 and others as late as day 8 from the time of injury. Duration of vasospasm was also variable with some children experiencing vasospasm for 1 day only and others for up to 8 days ( Table 3) . Flow velocity elevations for those diagnosed with vasospasm were well above the diagnostic criteria (Table 3 ). In the entire cohort, the mean number of sds above the age and gender normal value for the right MCA was 3.5 (± 1), for the left MCA was 3 (± 1), and for the BA was 3.8 (± 1.6). Several patients meeting diagnostic criteria for vasospasm also had clinical deterioration, reduction in brain tissue oxygenation, or imaging findings consistent with reduced cerebral blood flow (Table 3) . No patient who did not meet diagnostic criteria for vasospasm had similar changes to GCS or brain tissue oxygenation in the absence of elevated ICP or had evidence of vessel narrowing on MRI. An illustrative case of a patient experiencing vasospasm is shown in Figure 4 . No control patient met the diagnostic criteria for vasospasm on any of their TCD evaluations (15 patients, 90 TCD studies).
Several clinical factors were evaluated for correlation with the development of vasospasm ( Table 4 ). Being involved in a motor vehicle accident (odds ratio [OR], 4.7; 95% CI, 1.5-15; p = 0.01), higher ISS (OR, 1.1 for each point increase in ISS; 95% CI, 1.1-1.3; p = 0.04), fever above 38°C at admission (OR, 3.2; 95% CI, 1.1-9.5; p = 0.03), and having a postresuscitation GCS less than or equal to 8 (OR, 2.6; 95% CI, 1.2-8.4; p = 0.03) were identified as significant risk factors for the subsequent development of vasospasm on univariate analysis. On multivariate analysis when controlling for ISS and GCS, mechanism of injury (motor vehicle accident) remained an independent predictor for the development of vasospasm (OR, 3.5; 95% CI, 1.1-12.4; p = 0.04).
The mean duration of hospital stay for the entire cohort was 15 ± 14 days (range, 4-83 d). In those children who suffered moderate TBI, the mean GOS-E Peds at 1 month from the time of injury in those children without vasospasm was 2.4 (± 2) and in those with vasospasm was 4.4 (± 2.3) (p = 0.05). In these children, 76% of those without vasospasm had a favorable neurologic outcome compared with 40% in those who did meet criteria for vasospasm. In those children with severe TBI, the mean GOS-E Peds at 1 month from the time of injury in those children without vasospasm was 5 (± 2.5) compared with 5.8 (± 1.6) in those with vasospasm (p = 0.38). Twenty-nine percent of children with severe TBI who did not have vasospasm had a good neurologic outcome compared with 15% in those with vasospasm ( Fig. 5) .
DISCUSSION
The primary purpose of this investigation was to use TCD ultrasound to gain a description of the prevalence and time course of vasospasm in children who had suffered moderateto-severe TBI. This study included 69 children, which is the largest pediatric sample studied to date. We found a sizeable prevalence of vasospasm in this patient population (21%), particularly in those who had suffered severe head injury (33.5%). Mean time to onset of vasospasm in all vessels was postinjury day 4-5, and the mean duration of vasospasm was 1.5-2.5 days.
The reported prevalence of posttraumatic vasospasm in adults has varied widely with ranges from 11% to 60% (14) (15) (16) (17) . In the largest cohort of adult patients to date, Oertel et al (18) found that significant vasospasm occurred in the MCA 36% of the time and in the BA 19% of the time following TBI. In that study, peak onset of vasospasm was on postinjury day 3-4 in the MCA and day 2-4 in the BA. Most patients had resolution of anterior circulation spasm after 2.5 days and posterior circulation spasm after 3 days. The prevalence and time course of vasospasm in severely injured children in our study are similar to these findings.
In the only other pediatric study designed specifically to evaluate vasospasm following moderate-to-severe TBI, a higher prevalence of vasospasm than what we observed was found (36% in the MCA, 18% in the BA for the entire cohort) (19) . In that study, adult criteria for the diagnosis of vasospasm was used (MCA mean flow velocity > 120 cm/s with Lindegaard ratio ≥ 3, BA mean flow velocity > 90 cm/s). Adult criteria for vasospasm were initially developed by correlating TCD flow velocity to the degree of vasospasm measured on conventional angiography (6) (7) (8) . However, baseline flow velocities in children are elevated compared with adults (9, 10, 20, 21) . In addition, there are gender differences for normal flow velocities in children (9, 22, 23) . These two factors likely resulted in an overestimation of the prevalence of vasospasm in that study. Alternatively, it should be noted that vasospasm may not be a sustained phenomenon and may wax and wane. As TCD was performed only once daily in the current study, other patients may have transiently experienced vasospasm that we did not detect. Therefore, the true prevalence of vasospasm may be underreported here.
It should be noted that no controlled studies comparing TCD flow velocities with angiographic data in pediatric patients suspected of having vasospasm exist. Therefore, the main limitation of this study is that the diagnostic criteria, while based on expert opinion and commonly used to determine flow velocity abnormalities in children, have not been validated against findings on angiography. Validating criteria against angiography is likely to be difficult in pediatric patients. In our study, no control patient met diagnostic criteria for vasospasm. However, the control population included a relatively small number of individuals. Future studies could focus on including a larger control group to ensure that diagnostic criteria are not met in those with no known CNS trauma. Furthermore, future studies could use a standardized protocol comparing abnormal TCD flow velocities with cerebral blood flow alterations on magnetic resonance perfusion studies or abnormal vessel caliber on magnetic resonance angiogram.
Risk factors for the development of vasospasm on univariate analysis in our study included being involved in a motor vehicle collision, higher ISS, and a postresuscitation GCS less than or equal to 8. Several studies in adults have also clearly shown that more severely injured patients with lower admission GCSs are at higher risk for the development of vasospasm (15, 18, 24) . This finding is not surprising given leading theories on the pathophysiology of vasospasm following TBI. The cascade of events begins when the blood products deposited in or around the brain parenchyma at the time of the primary injury undergo phagocytosis by macrophages. During erythrocyte metabolism, oxygen-free radical species are generated. These toxic species scavenge electron donors from the lipid bilayer of the cell membrane of vascular endothelial and smooth-muscle cells. This results in a conformational change of these cell membranes with subsequent disruption and damage of the vascular wall. In response to this, up-regulation of production and secretion of potent vasoconstrictors, such as prostaglandins (PGH2/F2), serotonins (5-HT), endothelin-1 (Et-1), (25, 26) . In addition, oxygen-free radicals act on free hemoglobin and produce oxyhemoglobin. Nitric oxide, a potent inhibitor of vascular smooth muscle contraction and vasodilator, is bound and inactivated by oxyhemoglobin and contributes further to vasospasm (25) (26) (27) . More severely injured patients are likely to have more blood product deposition in and around the brain and thus, based on the mechanism described above, may be at higher risk of vasospasm than those less severely injured patients (28, 29) . On multivariate analysis, even when controlling for ISS and GCS, being involved in a motor vehicle accident remained an independent predictor for the development of vasospasm in the children in our study. One explanation for this finding could be that an additional pathophysiologic cascade may play a significant role in vasospasm development in pediatric patients who are involved in a motor vehicle accident. One such alternative mechanism that has been proposed in the literature is that direct stretching of cerebral arteries induces rho-associated kinases that lead to myogenic contraction of cerebral vessels (30, 31) . Bending, torsion, and displacement of these arteries only occur to the degree permitted by surrounding structures (30) . The biomechanical and anatomic differences in the child may make younger patients particularly susceptible to mechanical stretching of cerebral vessels at the time of rapid acceleration-deceleration that is seen in motor vehicle collisions. Specifically, the neck is weaker, the head is proportionally larger and heavier, the brain water content is higher, and supporting structures are less well developed in the child than in adults (32, 33) . Each of these factors may make children more prone to significant vessel stretching with subsequent development of vasospasm by this alternative mechanism.
One additional risk factor for the development of vasospasm on univariate analysis in our study was having a fever more than or equal to 38°C at admission. A recent study involving both adult and pediatric patients also found that fever at admission had a strong independent relationship to the development of posttraumatic vasospasm (34) . In their patients, despite protocol-directed therapies to maintain normothermia, patients developing vasospasm were more resistant to standard cooling measures. Those authors concluded that persistent activation of inflammatory pathways may be involved in the development of vasospasm after TBI. Further evidence supporting this possibility is that in a recent report, Armonda et al (35) note that aggressive maintenance of normothermia or mild hypothermia in patients with military blast injury resulted in a dramatic reduction of vasospasm from 47.5% to 5%. These findings together support the possibility of yet another potentially important mechanism that contributes to vasospasm in trauma patients.
Although being involved in a motor vehicle collision, having a higher ISS and a lower GCS, and fever at admission were associated with the development of vasospasm in this study, it is important to note that this does not necessarily imply causality. However, this study does identify the prevalence, time course, and a subset of pediatric patients who are at increased risk of developing vasospasm following moderate-to-severe head trauma. This is extremely important in that there are no current guidelines for the screening or management of vasospasm in these children. The information gained by this study is paramount for the development of these guidelines. Furthermore, standardized guidelines for the identification and management of vasospasm in these children are important because, through reduction of cerebral blood flow, vasospasm has been shown to result in cerebral ischemia and secondary brain injury. Studies in adult patients with TBI have reported an association between angiographically demonstrated vasospasm and neurologic deterioration as well as noncontusion-related infarcts (36, 37) . Chan et al (38) demonstrated a 17% rate of cerebral infarction on CT scans among TBI patients with associated vasospasm. Head trauma patients without vasospasm had no documented infarcts. Furthermore, nimodipine, intra-arterial papaverine, intra-arterial calcium-channel blockers, and balloon angioplasty have all been used to reduce vasospasm and improve clinical outcomes in adults with vasospasm following trauma (39) (40) (41) (42) (43) (44) (45) . Similar studies have not been performed in pediatric head trauma patients, largely due to the fact that until now, vasospasm has been an underrecognized phenomenon. Future studies need to be performed to determine the efficacy and impact of these therapies on children experiencing posttraumatic vasospasm. In addition, the association between fever and the development of vasospasm noted here and in other studies suggests that temperature control or antiinflammatory therapies could also be considered as both a therapeutic and preventative target for posttraumatic vasospasm in these patients.
CONClUSIONS
Our investigation revealed that vasospasm occurred in a sizeable number of children with TBI. Children in whom vasospasm developed were more likely to have been involved in a motor vehicle accident, had higher ISSs, had fever at admission, and had lower GCSs than in those whom vasospasm did not develop. Based on these findings, we recommend aggressive screening for posttraumatic vasospasm in these patients. Future studies should establish the relationship between vasospasm and long-term functional outcomes and should also evaluate potential preventative or therapeutic options for vasospasm in these children. Figure 5 . Good neurologic outcome (Glasgow Outcome Score Extended Pediatric version of ≥ 4) at 1 mo from injury was seen in 76% of those with moderate traumatic brain injury (TBI) without vasospasm and in 40% of those with vasospasm. In those with severe TBI, good neurologic outcome was seen in 29% of those children without vasospasm and in 15% of those with vasospasm.
